Little: Yes you are right. It has the rights in Australia and would have to negoiate rights for elsewhere; LNC and CNX can do as they please with their own technology.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%